Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1618)
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.08
Total Value
$123.20K
Shares Held After
883,735
% of Holdings
4.3%
VERACYTE, INC. (VCYT)
Wygant Jonathan — VP, Chief Accounting Officer
Shares
24,000
Price
$45.40
Total Value
$1.09M
Shares Held After
45,434
% of Holdings
34.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,478
Price
$26.00
Total Value
$64.43K
Shares Held After
28,523
% of Holdings
8.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
4,504
Price
$26.00
Total Value
$117.10K
Shares Held After
376,569
% of Holdings
1.2%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
2,254
Price
$35.08
Total Value
$79.07K
Shares Held After
97,656
% of Holdings
2.3%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
200
Price
$35.10
Total Value
$7.02K
Shares Held After
95,447
% of Holdings
0.2%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
2,032
Price
$35.08
Total Value
$71.28K
Shares Held After
95,647
% of Holdings
2.1%
Pennant Group, Inc. (PNTG)
Guerisoli Brent — Chief Executive Officer
Shares
22
Price
$34.86
Total Value
$766.92
Shares Held After
97,679
% of Holdings
0.0%
NewGenIvf Group Ltd (NIVF)
HRT FINANCIAL LP — 10% Owner
Shares
137,541
Price
$0.99
Total Value
$136.17K
Shares Held After
111,885
% of Holdings
122.9%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
1,165
Price
$5.69
Total Value
$6.63K
Shares Held After
194,924
% of Holdings
0.6%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,685
Price
$26.78
Total Value
$71.92K
Shares Held After
147,499
% of Holdings
1.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
10,926
Price
$26.78
Total Value
$292.65K
Shares Held After
479,989
% of Holdings
2.2%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,489
Price
$26.78
Total Value
$39.88K
Shares Held After
21,661
% of Holdings
6.4%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,861
Price
$26.78
Total Value
$49.85K
Shares Held After
55,780
% of Holdings
3.2%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
2,358
Price
$26.78
Total Value
$63.16K
Shares Held After
228,759
% of Holdings
1.0%
Glass House Brands Inc. (GLASF)
Tu William — SVP, Corporate Controller
Shares
10,414
Price
$10.19
Total Value
$106.12K
Shares Held After
5,423
% of Holdings
65.8%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
50
Price
$63.63
Total Value
$3.18K
Shares Held After
89,707
% of Holdings
0.1%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
1,254
Price
$62.93
Total Value
$78.91K
Shares Held After
89,757
% of Holdings
1.4%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
2,824
Price
$62.09
Total Value
$175.34K
Shares Held After
91,011
% of Holdings
3.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,176
Price
$19.00
Total Value
$41.34K
Shares Held After
62,371
% of Holdings
3.4%
Pelthos Therapeutics Inc. (PTHS)
Francis Knuettel II — CFO, Treas & Secty
Shares
1,500
Price
$26.84
Total Value
$40.26K
Shares Held After
11,316
% of Holdings
11.7%
Ainos, Inc. (AIMD)
lee ting-chuan — Director
Shares
9,302
Price
$1.57
Total Value
$14.60K
Shares Held After
917,405
% of Holdings
1.0%
GE HealthCare Technologies Inc. (GEHC)
Lobo Kevin — Director
Shares
10,000
Price
$64.18
Total Value
$641.80K
Shares Held After
14,363
% of Holdings
69.6%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
862
Price
$18.80
Total Value
$16.21K
Shares Held After
37,751
% of Holdings
2.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
87,425
Price
$0.45
Total Value
$39.34K
Shares Held After
831,635
% of Holdings
9.5%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
250,000
Price
$0.40
Total Value
$100.00K
Shares Held After
10,452,229
% of Holdings
2.4%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.52
Total Value
$1.54M
Shares Held After
1,073,095
% of Holdings
2.3%
MARIMED INC. (MRMD)
Levine Jon R — Director
Shares
20,000
Price
$0.07
Total Value
$1.49K
Shares Held After
21,307,986
% of Holdings
0.1%
MARIMED INC. (MRMD)
Levine Jon R — Director
Shares
37,000
Price
$0.07
Total Value
$2.77K
Shares Held After
21,287,986
% of Holdings
0.2%
MARIMED INC. (MRMD)
Levine Jon R — Director
Shares
3,000
Price
$0.08
Total Value
$230.10
Shares Held After
21,250,986
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
5,501
Price
$30.74
Total Value
$169.08K
Shares Held After
48,945
% of Holdings
10.1%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
24,406
Price
$118.67
Total Value
$2.90M
Shares Held After
60,034
% of Holdings
28.9%
Beta Bionics, Inc. (BBNX)
Lezack Adam — Director
Shares
998
Price
$11.21
Total Value
$11.19K
Shares Held After
27,399
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$569.73
Total Value
$91.16K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,181
Price
$568.86
Total Value
$671.82K
Shares Held After
40,673
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,407
Price
$568.00
Total Value
$2.50M
Shares Held After
41,854
% of Holdings
9.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,210
Price
$567.30
Total Value
$1.82M
Shares Held After
46,261
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
382
Price
$565.77
Total Value
$216.12K
Shares Held After
49,471
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
113
Price
$564.66
Total Value
$63.81K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
47
Price
$563.27
Total Value
$26.47K
Shares Held After
49,966
% of Holdings
0.1%
Vaxart, Inc. (VXRT)
Watson W. Mark — Director
Shares
10,000
Price
$0.65
Total Value
$6.53K
Shares Held After
134,125
% of Holdings
7.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
307
Price
$8.33
Total Value
$2.56K
Shares Held After
50,704
% of Holdings
0.6%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.93
Total Value
$19.30K
Shares Held After
20,000
% of Holdings
50.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$9.81
Total Value
$981.30K
Shares Held After
836,000
% of Holdings
12.0%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP & Chief Mfg and Supply Cha
Shares
18
Price
$439.80
Total Value
$7.92K
Shares Held After
1,523
% of Holdings
1.2%
electroCore, Inc. (ECOR)
Lev Joshua S. — CFO and Interim President
Shares
3,000
Price
$6.50
Total Value
$19.50K
Shares Held After
91,556
% of Holdings
3.2%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$30.27
Total Value
$6.05M
Shares Held After
1,613,063
% of Holdings
11.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
80
Price
$519.98
Total Value
$41.60K
Shares Held After
22,015
% of Holdings
0.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
782
Price
$518.76
Total Value
$405.67K
Shares Held After
22,095
% of Holdings
3.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
1,497
Price
$517.59
Total Value
$774.84K
Shares Held After
22,877
% of Holdings
6.1%
Showing 101–150 of 1618 transactions (page 3 of 33)